21. Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma. Issue 2 (18th July 2012) Authors: Cao, Yun; Zhang, Zhi‐Ling; Zhou, Ming; Elson, Paul; Rini, Brian; Aydin, Hakan; Feenstra, Kristin; Tan, Min‐Han; Berghuis, Bree; Tabbey, Rebeka; Resau, James H.; Zhou, Fang‐Jian; Teh, Bin Tean; Qian, Chao‐Nan Journal: Cancer Issue: Volume 119:Issue 2(2013) Page Start: 313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Progression‐free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma. Issue 1 (8th October 2013) Authors: Halabi, Susan; Rini, Brian; Escudier, Bernard; Stadler, Walter M.; Small, Eric J. Journal: Cancer Issue: Volume 120:Issue 1(2014) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Progression‐free survival as a surrogate endpoint of overall survival in patients with metastatic renal cell carcinoma. Issue 1 (8th October 2013) Authors: Halabi, Susan; Rini, Brian; Escudier, Bernard; Stadler, Walter M.; Small, Eric J. Journal: Cancer Issue: Volume 120:Issue 1(2014) Page Start: 52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Publisher Correction: Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma. (December 2018) Authors: McDermott, David; Huseni, Mahrukh; Atkins, Michael; Motzer, Robert; Rini, Brian; Escudier, Bernard; Fong, Lawrence; Joseph, Richard; Pal, Sumanta; Reeves, James; Sznol, Mario; Hainsworth, John; Rathmell, W.; Stadler, Walter; Hutson, Thomas; Gore, Martin; Ravaud, Alain; Bracarda, Sergio; Suárez, C... Journal: Nature medicine Issue: Volume 24:Number 12(2018) Page Start: 1941 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Relapse models for clear cell renal carcinoma – Authors' reply. Issue 8 (August 2015) Authors: Rini, Brian; Goddard, Audrey; Knezevic, Dejan; Escudier, Bernard Journal: Lancet oncology Issue: Volume 16:Issue 8(2015:Aug.) Page Start: e378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Relapse models for clear cell renal carcinoma – Authors' reply. Issue 8 (August 2015) Authors: Rini, Brian; Goddard, Audrey; Knezevic, Dejan; Escudier, Bernard Journal: Lancet oncology Issue: Volume 16:Issue 8(2015:Aug.) Page Start: e378 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. Response to post-axitinib treatment in patients with metastatic renal cell carcinoma. Issue 1 (December 2016) Authors: Chittoria, Namita; Haddad, Housam; Elson, Paul; Tannir, Nizar; Wood, Laura; Dreicer, Robert; Garcia, Jorge; Rini, Brian; Jonasch, Eric Journal: BMC cancer Issue: Volume 16:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of renal cell carcinoma. Issue 1 (December 2016) Authors: Rini, Brian; McDermott, David; Hammers, Hans; Bro, William; Bukowski, Ronald; Faba, Bernard; Faba, Jo; Figlin, Robert; Hutson, Thomas; Jonasch, Eric; Joseph, Richard; Leibovich, Bradley; Olencki, Thomas; Pantuck, Allan; Quinn, David; Seery, Virginia; Voss, Martin; Wood, Christopher; Wood, Laura; ... Journal: Journal for immunotherapy of cancer Issue: Volume 4:Issue 1(2016) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. The use of sunitinib in renal cell carcinoma: where are we now?. Issue 9 (September 2014) Authors: Czarnecka, Anna M; Szczylik, Cezary; Rini, Brian Journal: Expert review of anticancer therapy Issue: Volume 14:Issue 9(2014) Page Start: 983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. The use of sunitinib in renal cell carcinoma: where are we now?. Issue 9 (September 2014) Authors: Czarnecka, Anna M; Szczylik, Cezary; Rini, Brian Journal: Expert review of anticancer therapy Issue: Volume 14:Issue 9(2014) Page Start: 983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗